ALNYLAM PHARMACEUTICALS, INC. (ALNY) Other
Market cap
$41.2B
P/E ratio
133.5x
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | -4.2 | -21.8 | -9.1 | -2.8 | -7.4 | -8.5 | -8.7 | -11.8 | -13.9 | -8.4 | -7.3 | -5.8 | -3.7 | -2.1 | 6.8 |
| Return on equity (%) | - | - |